Alter, Harvey J.

Publishing since 1970 (Dinosaur)

Has published 212 publications in 41 years

Number of publications published per year by Alter, Harvey J.. (Source : PubMed)

Distribution of publications types for Alter, Harvey J.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Yu MY, Alter HJ, Virata-Theimer ML, Geng Y, Ma L, Schechterly CA, Colvin CA, Luban NL. Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples.  Transfusion  2010  
•  Pos Z, Selleri S, Spivey TL, Wang JK, Liu H, Worschech A, Sabatino M, Monaco A, Leitman SF, Falus A, Wang E, Alter HJ, Marincola FM. Genomic scale analysis of racial impact on response to IFN-alpha.  Proc. Natl. Acad. Sci. U.S.A.  2010;107;2  
•  Allison RD, Katsounas A, Koziol DE, Kleiner DE, Alter HJ, Lempicki RA, Wood B, Yang J, Fullmer B, Cortez KJ, Polis MA, Kottilil S. Association of interleukin-15-induced peripheral immune activation with hepatic stellate cell activation in persons coinfected with hepatitis C virus and HIV.  J. Infect. Dis.  2009;200;4  
•  Zhang P, Zhong L, Struble EB, Watanabe H, Kachko A, Mihalik K, Virata-Theimer ML, Alter HJ, Feinstone S, Major M. Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity.  Proc. Natl. Acad. Sci. U.S.A.  2009;106;18  
•  Burbelo PD, Issa AT, Ching KH, Exner M, Drew WL, Alter HJ, Iadarola MJ. Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies.  Virol. J.  2009;6  
•  Qiu Q, Wang RY, Jiao X, Jin B, Sugauchi F, Grandinetti T, Alter HJ, Shih JW. Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants.  Vaccine  2008;26;43  
•  Alter HJ, Klein HG. The hazards of blood transfusion in historical perspective.  Blood  2008;112;7  
•  Alter HJ. Pathogen reduction: a precautionary principle paradigm.  Transfus Med Rev  2008;22;2  
•  Scheel TK, Gottwein JM, Jensen TB, Prentoe JC, Hoegh AM, Alter HJ, Eugen-Olsen J, Bukh J. Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.  Proc. Natl. Acad. Sci. U.S.A.  2008;105;3  
•  Jin B, Wang RY, Qiu Q, Sugauchi F, Grandinetti T, Alter HJ, Shih JW. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.  Immunology  2007;122;1  

[ See timeline ] [ See all publications ]